Vilmann Peter, Săftoiu Adrian
Department of Surgical Gastroenterology, Gentofte University Hospital, Copenhagen, Denmark.
J Gastroenterol Hepatol. 2006 Nov;21(11):1646-55. doi: 10.1111/j.1440-1746.2006.04475.x.
Endoscopic ultrasound-guided fine needle aspiration biopsy (EUS-FNA) is currently performed on a routine basis at many endoscopic centers and it is evident that this procedure has a major impact on the therapeutic management of patients by obtaining a definite tissue diagnosis from lesions outlined by endosonography. The reported yield of EUS-FNA is about 90-95%, with an overall sensitivity and specificity of 90% and 100%, respectively. Moreover, even minute lesions down to a size of 5 mm may be imaged and consequently biopsied. This Review describes the technique of EUS-FNA in detail, based on a literature review and the authors' extensive experience with this method. The endoscopes and needle systems available on the market are presented in detail. The biopsy procedure is carefully explained, as well as the preparation of the cytology smears. Finally, the limitations and complications of the procedure are reviewed in brief, stressing the low rate of complications (below 1-2%), most of them being minor and self-limiting. Currently endosonography has strengthened its position as a diagnostic and staging method, especially after establishing the method of FNA biopsy. Thus, EUS-FNA is very useful to establish an initial tissue diagnosis of malignancy, but also to accurately stage the patients preoperatively, influencing the decision-making process and reducing the morbidity and mortality that accompanies inappropriate surgical interventions in patients with advanced cancer.
内镜超声引导下细针穿刺活检(EUS-FNA)目前在许多内镜中心已成为常规操作,显然该操作通过从内镜超声勾勒出的病变中获取明确的组织诊断,对患者的治疗管理产生了重大影响。据报道,EUS-FNA的取材成功率约为90%-95%,总体敏感性和特异性分别为90%和100%。此外,即使是小至5毫米的微小病变也可以成像并进行活检。本综述基于文献回顾和作者对该方法的丰富经验,详细描述了EUS-FNA技术。详细介绍了市场上现有的内镜和穿刺针系统。仔细解释了活检操作过程以及细胞学涂片的制备。最后,简要回顾了该操作的局限性和并发症,强调并发症发生率较低(低于1%-2%),大多数为轻微且自限性。目前,内镜超声已巩固了其作为诊断和分期方法的地位,尤其是在确立了FNA活检方法之后。因此,EUS-FNA对于确立恶性肿瘤的初始组织诊断非常有用,而且对于准确进行患者术前分期也很有用,它影响决策过程,并降低晚期癌症患者不适当手术干预带来的发病率和死亡率。